4//SEC Filing
DeLuca Richard R. 4
Accession 0001127602-25-013049
CIK 0000310158other
Filed
Apr 30, 8:00 PM ET
Accepted
May 1, 6:10 PM ET
Size
9.5 KB
Accession
0001127602-25-013049
Insider Transaction Report
Form 4
DeLuca Richard R.
EVP&Pres, Merck Animal Health
Transactions
- Award
Restricted Stock Unit
2025-04-29+7,555→ 7,555 totalFrom: 2026-04-29Exp: 2028-04-29→ Common Stock (7,555 underlying) - Award
Stock Option (Right to Buy)
2025-04-29+34,390→ 34,390 totalExercise: $84.71From: 2026-04-29Exp: 2035-04-28→ Common Stock (34,390 underlying)
Holdings
- 180,729.7
Common Stock
- 1,281.196(indirect: By 401(k))
Common Stock - 401(k) Plan
Footnotes (5)
- [F1]Holdings include shares acquired in dividend reinvestment transactions.
- [F2]Includes shares acquired and dividends earned through April 7, 2025 in the Merck U.S. Savings Plan, a 401(k) plan.
- [F3]Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
- [F4]These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 4/29/2026, 4/29/2027 and 4/29/2028.
- [F5]The option vests and becomes exercisable in three equal installments on 4/29/2026, 4/29/2027 and 4/29/2028.
Documents
Issuer
Merck & Co., Inc.
CIK 0000310158
Entity typeother
Related Parties
1- filerCIK 0001421339
Filing Metadata
- Form type
- 4
- Filed
- Apr 30, 8:00 PM ET
- Accepted
- May 1, 6:10 PM ET
- Size
- 9.5 KB